Yao-Jen Liang

Dr. Yao-Jen Liang

Institute and Department of Life Science, Fu-Jen University, 242 No.510, Zhongzheng Rd., Xinzhuang Dist., New Taipei City 242062, Taiwan

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 March 2015 in Marine Drugs
Verified
Journal Article
Open access
PDF file
JWJyun-Yuan Wang
Jyun-Yuan Wang
YLYue-Jia Lee
Yue-Jia Lee
MCMei-Chia Chou
Mei-Chia Chou
RCRenin Chang
Renin Chang
CCChih-Hsien Chiu
Chih-Hsien Chiu
LWLeang-Shin Wu
Leang-Shin Wu
Androgens, especially testosterone produced in Leydig cells, play an essential role in development of the male reproductive phenotype and fertility. However, testicular oxidative stress may cause a decline in testosterone production. Many antioxidants have been used as reactive oxygen species (ROS) scavengers to eliminate oxidative stress to protect steroidogenesis. Astaxanthin (AST), a natural extract from algae and plants ubiquitous in the marine environment, has been shown to have antioxidant activity in many previous studies. In this study, we treated primary mouse Leydig cells or MA-10 cells with hydrogen peroxide (H2O2) to cause oxidative stress. Testosterone and progesterone production was suppressed and the expression of the mature (30 kDa) form of StAR protein was down-regulated in MA-10 cells by H2O2 and cAMP co-treatment. However, progesterone production and expression of mature StAR protein were restored in MA-10 cells by a one-hour pretreatment with AST. AST also reduced ROS levels in cells so that they were lower than the levels in untreated controls. These results provide additional evidence of the potential health benefits of AST as a potential food additive to ease oxidative stress.

27 June 2010 in Diabetes/Metabolism Research and Reviews
Verified
Journal Article
Closed access
PDF file
Yao-Jen LiangYao-Jen Liang
Yao-Jen Liang
JJJhin‐Hao Jian
Jhin‐Hao Jian
YLYuan‐Chun Liu
Yuan‐Chun Liu
SJShiow‐Jen Juang
Shiow‐Jen Juang
KSKou‐Gi Shyu
Kou‐Gi Shyu
JLJyh‐Gang Leu
Jyh‐Gang Leu

7 February 2020 in Diagnostics
Verified
Journal Article
Open access
PDF file
Chung-Tsui HuangChung-Tsui Huang
Chung-Tsui Huang
CLCheng-Kuan Lin
Cheng-Kuan Lin
TLTzong-Hsi Lee
Tzong-Hsi Lee
Yao-Jen LiangYao-Jen Liang
Yao-Jen Liang
Pancreatic fibrosis is the dominant reversible pathological change and diagnostic factor in early chronic pancreatitis, defined by a mechanistic approach proposed in 2016. Main guidelines for chronic pancreatitis were published by the American Pancreas Association in 2014, the Japanese Society of Gastroenterology in 2015, and United European Gastroenterology in 2017. All three sets of guidelines mentioned that the staging of chronic pancreatitis is important but challenging. There are various image modalities for the non-histologic diagnosis of pancreatic fibrosis: (1) shear wave elastography, such as an acoustic radiation force impulse with a cut-off value of 1.4 m/s; (2) strain elastography using grades of strain; (3) endoscopic ultrasonography using the Rosemont criteria or endoscopic ultrasound criteria for early chronic pancreatitis proposed by the Japan Pancreas Society; (4) computed tomography using the Hounsfield scale or number of micro-calcifications; and (5) magnetic resonance imaging using the apparent diffusion coefficient and the T1w flash and T2w HASTE sequences. The clinical applications are to (1) evaluate pancreatic tumors and inflammatory disease; (2) monitor dyspepsia with early chronic pancreatitis; (3) monitor individuals with a high risk of pancreatic cancer; (4) analyze a fatty pancreas with fibrosis; (5) predict a fistula after pancreatic surgery; and (6) predict outcomes for chronic pancreatitis or pancreatic cancer. The selection of tools will be dependent on the clinical scenario. Conclusion: There are various modalities for the non-histologic diagnosis of pancreatic fibrosis. The selection of the optimal device will be dependent on the clinical scenario.

1 January 2018 in European Journal of Pharmacology
Verified
Journal Article
Closed access
JLJyh-Gang Leu
Jyh-Gang Leu
MCMing-Hsing Chiang
Ming-Hsing Chiang
CCChao-Yi Chen
Chao-Yi Chen
JLJiun-Tsai Lin
Jiun-Tsai Lin
HCHan-Min Chen
Han-Min Chen
Yao-Jen LiangYao-Jen Liang
Yao-Jen Liang


1 November 2021 in European Journal of Pharmacology
Verified
Journal Article
Closed access
JLJyh-Gang Leu
Jyh-Gang Leu
WSWei-Hsiang Su
Wei-Hsiang Su
YCYu-Cheng Chen
Yu-Cheng Chen
Yao-Jen LiangYao-Jen Liang
Yao-Jen Liang